Clinical outcomes (CO) for special populations of patients (pts) with advanced non-small cell lung cancer (NSCLC): Results from ARIES, a bevacizumab (BV) observational cohort study (OCS).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 7618-7618 ◽  
Author(s):  
A. J. Wozniak ◽  
J. Garst ◽  
M. Jahanzeb ◽  
M. P. Kosty ◽  
R. Vidaver ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document